30 closest matches · ranked by relevance
Knee Osteoarthritis
Primary: Number of Participants With Successful Knee Injection — 17; 14; 13; 7 Participants
Trigger Finger
Primary: Difference in Visual-analog Score (VAS) for Anticipated Pain Prior to Injection and Actual Pain After Injection — 1.6; 2.8 units on a scale
Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Lipohypertrophy
Primary: Change in Glycemic Control — 8.99; 8.20 % of glycated hemoglobin
Edematous Skin
Primary: Aesthetic Appearance Improvement Likert Scores by Treatment Region at Day 22 — 1.08; 1.10; 0.75; 0.50 score on a scale
Healthy
Primary: The Number of Injections With Local Site Reactions (Bleeding, Swelling, Bruising and Erythema). — 0; 51; 0; 0 injections
Sacroiliitis
Primary: Difference in Minutes Between a Sacroiliac Joint Injection Done With Ultrasound vs Fluoroscopy — 9.471; 9.552 minutes
Chronic Plantar Fasciitis
Primary: Visual Analog Scale Score - General Heel Tenderness — 46.7; 47.5 score on a scale
Age-related Macular Degeneration · Central Retinal Vein Occlusion · Diabetic Macular Edema
Primary: Number of Participants Who Preferred Subconjunctival Anesthetic at the Third Follow-up Visit — 50 participants
Keloid · Alopecia Areata · Acne
Primary: Pain Outcome: Visual Analog Scale — 5.4; 2.7 Score on a scale
Intra-articular Injections
Primary: True Positive Detection of Synovial Fluid Marked in Case Report Form — 86 percentage of injected joints
Lateral Elbow Pain
Primary: Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire — 18; 13 units on a scale
Cervical Radiculopathy
Primary: Injection Dispersal Patterns Measured (in cm) in the Superoinferior Directions on Post-injection MRI With a Calibrated Internal Measurement Software. — 14.73 cm
Bursitis
Primary: Pain Intensity Measured on Visual Analog Scale and Percent Improvement
Osteoarthritis (OA) of the Knee
Primary: Change in Mean Cartilage Thickness in the Index Compartment (Compartment With the Most Damage) — -0.21; -0.10 mm
Pain
Primary: Change in Pain Score on FLACC Scale From Device Deployment to Venipuncture — 1.71; 2.82; 0.23 units on a scale — p=0.0001
Pain
Primary: Pain, Measured as Units on a Scale — 4.0; 4.8 units on scale, 0-5
Immunotherapy · Allergy
Primary: Change in Patient Pain Perception Utilizing Three Non-pharmacological Pain Control / Distraction Devices and Ethyl Chloride Spray — 1.33; 2.22; 2.25; 1.45 score on a scale
Testosterone Deficiency · Hypogonadism, Male
Primary: Change in Levels of Serum Total Testosterone Concentration — NA; 1043.6; NA; 785.7 ng/dl
Root Canal Infection
Primary: Number of Participants With Successful Injection Technique Assessed by Verbal Rating Scale (VRS) — 16; 37; 29; 26 Participants
Influenza, Human
Primary: Anti Influenza Type A/H1N1 Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titer (GMT) — 4.43; 4.38; 5.64; 5.64 Titers
Osteoarthritis,Knee
Primary: Numerical Rating Scale (NRS) Pain Scores During Hospitalization. — 1.06; 1.90; 2.67; 1.60 scores on a scale 0-10
Cheek Augmentation · Midface Contour Deficiencies
Primary: Number of Participants With Treatment-Emergent Adverse Events [Safety] — 5 Participants
Trigger Finger
Primary: Pain Outcome: Visual Analog Scale — 3.5; 2 score on a scale
Aesthetic Dermatology
Primary: Performance at 1 Month Investigator Overall VISCOL Range — 77 Participants — p=<0.0001
Diabetes · Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2
Primary: Injection Pain (VAS mm) — 20.0; 12.8; NA; NA mm
Knee Injury
Primary: Baseline Pain Assessment Before Knee Arthroscopy Via the Visual Analog Scale. — .25; .43 score on a scale
Overactive Bladder
Primary: Participant Discomfort Related to BTX-A Injection — 3.2; 3.6 score on a scale — p=0.21
Osteoarthritis, Knee
Primary: Pain( Visual Analog Scale ) — 2.3; 6.4 units on a scale
Knee Osteoarthritis
Primary: Visual Analog Pain Score — 2.49; 3.25 score on a scale
Lip Augmentation and Correction of Perioral Rhytids
Primary: Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine — 11 Participants